RanBaxy Pharmaceuticals Inc. (subsidiary of SUN PHARMA Company, Princeton, NJ) is currently manufacturing a drug that has
Question:
RanBaxy Pharmaceuticals Inc. (subsidiary of SUN PHARMA Company, Princeton, NJ) is currently manufacturing a drug that has a variable cost and selling price of $1.20 per unit $2.00 respectively (in U.S. dollars). The current fixed costs are $25,000, and the sales volume is 25,000 units. The company is considering adding new equipment to the production that can improve the production efficiency of this drug. The new equipment will add an additional $9,000 to the fixed cost, and variable cost per unit would decrease to $1.00. At what sales volume would adding this new equipment be profitable?
Fantastic news! We've Found the answer you've been seeking!
Step by Step Answer:
Related Book For
Operations Management Managing Global Supply Chains
ISBN: 978-1506302935
1st edition
Authors: Ray R. Venkataraman, Jeffrey K. Pinto
Question Posted: